Ferroptosis and tumor drug resistance: current status and major challenges
Z Nie, M Chen, Y Gao, D Huang, H Cao… - Frontiers in …, 2022 - frontiersin.org
Ferroptosis is a novel type of regulated cell death, whose unique metabolic characteristics
are commonly used to evaluate the conditions of various diseases especially in tumors …
are commonly used to evaluate the conditions of various diseases especially in tumors …
[HTML][HTML] HIV and lymphoma: from epidemiology to clinical management
A Re, C Cattaneo, G Rossi - Mediterranean journal of hematology …, 2019 - ncbi.nlm.nih.gov
Patients infected with human immunodeficiency virus (HIV) are at increased risk for
developing both non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL). Even if this …
developing both non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL). Even if this …
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era
C Besson, R Lancar, S Prevot, M Algarte-Genin… - Aids, 2017 - journals.lww.com
Objective: Non-Hodgkin's lymphoma (NHL) remains among the most frequent malignancies
in persons living with HIV (PLWHIV). Survival among patients with HIV-associated diffuse …
in persons living with HIV (PLWHIV). Survival among patients with HIV-associated diffuse …
Malignant lymphoma in the HIV‐positive patient
A Meister, M Hentrich, C Wyen… - European journal of …, 2018 - Wiley Online Library
The introduction of combination antiretroviral therapy (cART) drastically improved
performance status, immune function, and life expectancy of HIV‐infected individuals. In …
performance status, immune function, and life expectancy of HIV‐infected individuals. In …
[HTML][HTML] Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study
Outcome of HIV-infected patients with AIDS-related lymphomas has improved during recent
years. However, data on incidence, risk factors, and outcome of relapses in AIDS-related …
years. However, data on incidence, risk factors, and outcome of relapses in AIDS-related …
Human Immunodeficiency Virus Related Non-Hodgkin's Lymphoma
T Gessese, F Asrie, Z Mulatie - Blood and Lymphatic Cancer …, 2023 - Taylor & Francis
Human immunodeficiency virus infection is related with an increased risk of hematological
malignancy principally, non-Hodgkin lymphoma. Most non-Hodgkin lymphomas are …
malignancy principally, non-Hodgkin lymphoma. Most non-Hodgkin lymphomas are …
Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia
EG Weagel, W Meng, MH Townsend… - OncoTargets and …, 2017 - Taylor & Francis
TK1 is an enzyme involved in DNA synthesis and repair. TK1 is usually found elevated in
cancer patients' serum, which makes it a useful tumor proliferation biomarker that strongly …
cancer patients' serum, which makes it a useful tumor proliferation biomarker that strongly …
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV
Objective: Chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infections are
associated with increased risks of lymphomas in the non-HIV setting. Their impacts on HIV …
associated with increased risks of lymphomas in the non-HIV setting. Their impacts on HIV …
In situ BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort study
L Philippe, R Lancar, C Laurent… - British Journal of …, 2020 - Wiley Online Library
The prognostic value of cell of origin (COO) classification and BCL2 expression is not well
established in diffuse large B‐cell lymphoma (DLBCL) patients with human …
established in diffuse large B‐cell lymphoma (DLBCL) patients with human …
[HTML][HTML] IgG abnormalities in HIV-positive Malawian women initiating antiretroviral therapy during pregnancy persist after 24 months of treatment
Objectives Hypergammaglobulinemia and anomalies in the IgG subclass distribution are
common in HIV-infected individuals and persist even after many years of antiretroviral …
common in HIV-infected individuals and persist even after many years of antiretroviral …